Allergan Inc. (AGN) News Nov 17, 2014, 7:55 p.m.
Post# of 250602
Posted On: 11/17/2014 9:41:27 PM
Allergan Inc. (AGN) News Nov 17, 2014, 7:55 p.m.
MarketWatch News on AGN
S&P 500 registers 42nd record close in skittish market 4:59 p.m. Today - Carla Mozee
Urban Outfitters slides after earnings miss expectations 4:43 p.m. Today - Sue Chang
Valeant says it won’t meet Actavis’s offer 12:18 p.m. Today - Russ Britt
If you're looking big pharma, look no further than Actavis 11:33 a.m. Today - The Trading Deck
Newscast: It's Merger Mania Monday 9:57 a.m. Today - MarketWatch
Actavis to buy Allergan in $66 billion deal 9:35 a.m. Today - Jonathan D. Rockoff
Actavis confirms to buy Allergan in $66 billion deal 9:30 a.m. Today - Ciara Linnane
Mon., Nov. 17: Pfizer Stock After Pre-Market Drop 9:24 a.m. Today - MarketWatch
Actavis, Allergan close to a deal 8:33 a.m. Today - Jonathan D. Rockoff
Allergan's stock jumps 4.2% premarket after report of potential merger deal 8:22 a.m. Today - Tomi Kilgore
Allergan near a buyout deal worth up to 65 billion 4:30 a.m. Today - MarketWatch
Allergan, Actavis near cash-and-stock deal: WSJ 1:48 p.m. Nov. 16, 2014 - Andria Cheng
Paulson takes stake in Abbvie, adds to Shire holdings 6:46 p.m. Nov. 14, 2014 - MarketWatch
Aegon profit hit by mortality changes 2:14 a.m. Nov. 13, 2014 - MarketWatch.com
Drug companies Salix, Intercept reeling after earnings, drama 12:15 p.m. Nov. 7, 2014 - Russ Britt
Ackman urges Allergan to open sale process, negotiate 10:33 a.m. Nov. 7, 2014 - Chelsey Dulaney
Bill Ackman scores critical win in Valeant-Allergan takeover war 4:23 p.m. Nov. 4, 2014 - Russ Britt
Regeneron skids on shortfall in Eylea sales 11:15 a.m. Nov. 4, 2014 - Russ Britt
4 more ‘Amazon’ stocks you may want to avoid 8:43 p.m. Oct. 27, 2014 - Philip van Doorn
Twitter shares drop in wake of quarterly results 5:07 p.m. Oct. 27, 2014 - Sue Chang
Loading more headlines...
Advertisement
Other News on AGN
Jim Cramer's 'Mad Money' Recap: When Bad News Is Really Good News for Us 8:09 p.m. Today - TheStreet.com
Deal Boom Feeds on Surging Stocks 7:33 p.m. Today - The Wall Street Journal Interactive Edition
Actavis to Buy Allergan for $66 Billion 7:24 p.m. Today - The Wall Street Journal Interactive Edition
Jack Lew, Irish Hero 7:06 p.m. Today - The Wall Street Journal Interactive Edition
Merck Updates on Anti-PD-1 Drug Keytruda Phase II Study - Analyst Blog 6:30 p.m. Today - Zacks.com
Bristol-Myers Squibb Reports Positive Opdivo Phase III Data - Analyst Blog 6:20 p.m. Today - Zacks.com
Here Are Some Big Caps Poised To Make Gains 5:45 p.m. Today - Investors Business Daily
Five Ethical Drugmakers Keep Leadership Positions 5:27 p.m. Today - Investors Business Daily
Actavis' $66 Bil Offer Steals Allergan From Valeant 4:31 p.m. Today - Investors Business Daily
Stock Market Today: Japan Recession Keeps Markets From Celebrating Deals Deluge 4:15 p.m. Today - TheStreet.com
Actavis-Allergan Deal Paves Way for Tax Savings 1:38 p.m. Today - The Wall Street Journal Interactive Edition
Stock Market Today: Stocks Are Mixed as Corporate Deals Offset Japan's Recession 1:16 p.m. Today - TheStreet.com
Pershing Square wins big on Actavis buy 12:22 p.m. Today - Seeking Alpha
Cramer: Investors Should Ignore Analysts' Calls on Hotel, Other Stocks 11:32 a.m. Today - TheStreet.com
Allergan's $66 Billion Actavis Deal is Still a Win for Bill Ackman 10:59 a.m. Today - TheStreet.com
Benzinga's Volume Movers 9:29 a.m. Today - benzinga.com
Actavis Nabs Allergan For $66 Billion; Valeant Folds 9:17 a.m. Today - Investors Business Daily
Actavis plc Buying Allergan In $66 Billion Deal 9:06 a.m. Today - benzinga.com
Actavis (ACT) to Buy Botox Maker Allergan (AGN) 7:41 a.m. Today - InvestorPlace.com
Invest Like Kim Kardashian - Investment Ideas 4:09 a.m. Today - Zacks.com
Loading more headlines...
Press Releases on AGN
Fitch: Allergan Purchase by Actavis Would Pressure Ratings 1:44 p.m. Today - BusinessWire - BZX
Fitch Affirms Actavis at 'BBB-' on Allergan Acquisition Announcement; Outlook Stable 12:20 p.m. Today - BusinessWire - BZX
ALLERGAN SHAREHOLDER ALERT:Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Actavis 11:16 a.m. Today - BusinessWire - BZX
ALLERGAN, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 10:32 a.m. Today - PR Newswire - PRF
Valeant Comments On Allergan Announcement 9:29 a.m. Today - PR Newswire - PRF
Actavis to Acquire Allergan to Create Top 10 Global Growth Pharmaceutical Company with $23 Billion in Revenue 9:15 a.m. Today - PR Newswire - PRF
Physicians Continue to Voice Strong Support for Allergan via Open Letters to the Eye Care Community 9:00 a.m. Nov. 14, 2014 - BusinessWire - BZX
FDA Approves New Styles of Allergan’s NATRELLE® 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants 4:50 p.m. Nov. 12, 2014 - BusinessWire - BZX
Allergan Board of Directors Announces Approval of Amendments to Company’s Bylaws 7:02 a.m. Nov. 12, 2014 - BusinessWire - BZX
New Survey Reveals What Women in the U.S. Really Want to Know About BOTOX® Cosmetic (onabotulinumtoxinA) 8:47 a.m. Nov. 11, 2014 - PR Newswire - PRF
Ad hoc: Biofrontera to take over the sales and marketing of Ameluz(R) in Spain from Allergan 3:20 a.m. Nov. 7, 2014 - Thomson Reuters ONE
New Survey Shows Nearly 60% Of Women Say They Would Rather Have A More Youthful Looking Face Than A More Youthful Looking Body(1) 4:25 p.m. Nov. 5, 2014 - PR Newswire - PRF
Ipsen Biopharmaceuticals, Inc. Announces Hire of Donald Pearl as Vice President of Neurology 9:37 a.m. Nov. 5, 2014 - BusinessWire - BZX
Allergan Comments on California Federal Court Ruling in Insider Trading Lawsuit against Valeant & Pershing Square 1:56 p.m. Nov. 4, 2014 - BusinessWire - BZX
Valeant And Pershing Square May Vote At Special Meeting 1:27 p.m. Nov. 4, 2014 - PR Newswire - PRF
Quarterly Financial & Operational Results Release and Dividends - Research Reports on AFLAC, BlackRock, Allergan, Cabot and Cheniere Energy 8:40 a.m. Nov. 3, 2014 - PR Newswire - PRF
Allergan Canada Launches a 3D JUVEDERM(R) Visualization iPad App Powered by ModiFace 9:02 a.m. Oct. 29, 2014 - Marketwired
Allergan Comments on Valeant Letter 9:10 a.m. Oct. 27, 2014 - BusinessWire - BZX
Allergan Announces Quarterly Conference Call 1:00 p.m. Oct. 24, 2014 - BusinessWire - BZX
Global Pediatric Drugs and Vaccines Market 5:08 p.m. Oct. 23, 2014 - PR Newswire - PRF
Loading more headlines...
MarketWatch News on AGN
S&P 500 registers 42nd record close in skittish market 4:59 p.m. Today - Carla Mozee
Urban Outfitters slides after earnings miss expectations 4:43 p.m. Today - Sue Chang
Valeant says it won’t meet Actavis’s offer 12:18 p.m. Today - Russ Britt
If you're looking big pharma, look no further than Actavis 11:33 a.m. Today - The Trading Deck
Newscast: It's Merger Mania Monday 9:57 a.m. Today - MarketWatch
Actavis to buy Allergan in $66 billion deal 9:35 a.m. Today - Jonathan D. Rockoff
Actavis confirms to buy Allergan in $66 billion deal 9:30 a.m. Today - Ciara Linnane
Mon., Nov. 17: Pfizer Stock After Pre-Market Drop 9:24 a.m. Today - MarketWatch
Actavis, Allergan close to a deal 8:33 a.m. Today - Jonathan D. Rockoff
Allergan's stock jumps 4.2% premarket after report of potential merger deal 8:22 a.m. Today - Tomi Kilgore
Allergan near a buyout deal worth up to 65 billion 4:30 a.m. Today - MarketWatch
Allergan, Actavis near cash-and-stock deal: WSJ 1:48 p.m. Nov. 16, 2014 - Andria Cheng
Paulson takes stake in Abbvie, adds to Shire holdings 6:46 p.m. Nov. 14, 2014 - MarketWatch
Aegon profit hit by mortality changes 2:14 a.m. Nov. 13, 2014 - MarketWatch.com
Drug companies Salix, Intercept reeling after earnings, drama 12:15 p.m. Nov. 7, 2014 - Russ Britt
Ackman urges Allergan to open sale process, negotiate 10:33 a.m. Nov. 7, 2014 - Chelsey Dulaney
Bill Ackman scores critical win in Valeant-Allergan takeover war 4:23 p.m. Nov. 4, 2014 - Russ Britt
Regeneron skids on shortfall in Eylea sales 11:15 a.m. Nov. 4, 2014 - Russ Britt
4 more ‘Amazon’ stocks you may want to avoid 8:43 p.m. Oct. 27, 2014 - Philip van Doorn
Twitter shares drop in wake of quarterly results 5:07 p.m. Oct. 27, 2014 - Sue Chang
Loading more headlines...
Advertisement
Other News on AGN
Jim Cramer's 'Mad Money' Recap: When Bad News Is Really Good News for Us 8:09 p.m. Today - TheStreet.com
Deal Boom Feeds on Surging Stocks 7:33 p.m. Today - The Wall Street Journal Interactive Edition
Actavis to Buy Allergan for $66 Billion 7:24 p.m. Today - The Wall Street Journal Interactive Edition
Jack Lew, Irish Hero 7:06 p.m. Today - The Wall Street Journal Interactive Edition
Merck Updates on Anti-PD-1 Drug Keytruda Phase II Study - Analyst Blog 6:30 p.m. Today - Zacks.com
Bristol-Myers Squibb Reports Positive Opdivo Phase III Data - Analyst Blog 6:20 p.m. Today - Zacks.com
Here Are Some Big Caps Poised To Make Gains 5:45 p.m. Today - Investors Business Daily
Five Ethical Drugmakers Keep Leadership Positions 5:27 p.m. Today - Investors Business Daily
Actavis' $66 Bil Offer Steals Allergan From Valeant 4:31 p.m. Today - Investors Business Daily
Stock Market Today: Japan Recession Keeps Markets From Celebrating Deals Deluge 4:15 p.m. Today - TheStreet.com
Actavis-Allergan Deal Paves Way for Tax Savings 1:38 p.m. Today - The Wall Street Journal Interactive Edition
Stock Market Today: Stocks Are Mixed as Corporate Deals Offset Japan's Recession 1:16 p.m. Today - TheStreet.com
Pershing Square wins big on Actavis buy 12:22 p.m. Today - Seeking Alpha
Cramer: Investors Should Ignore Analysts' Calls on Hotel, Other Stocks 11:32 a.m. Today - TheStreet.com
Allergan's $66 Billion Actavis Deal is Still a Win for Bill Ackman 10:59 a.m. Today - TheStreet.com
Benzinga's Volume Movers 9:29 a.m. Today - benzinga.com
Actavis Nabs Allergan For $66 Billion; Valeant Folds 9:17 a.m. Today - Investors Business Daily
Actavis plc Buying Allergan In $66 Billion Deal 9:06 a.m. Today - benzinga.com
Actavis (ACT) to Buy Botox Maker Allergan (AGN) 7:41 a.m. Today - InvestorPlace.com
Invest Like Kim Kardashian - Investment Ideas 4:09 a.m. Today - Zacks.com
Loading more headlines...
Press Releases on AGN
Fitch: Allergan Purchase by Actavis Would Pressure Ratings 1:44 p.m. Today - BusinessWire - BZX
Fitch Affirms Actavis at 'BBB-' on Allergan Acquisition Announcement; Outlook Stable 12:20 p.m. Today - BusinessWire - BZX
ALLERGAN SHAREHOLDER ALERT:Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Actavis 11:16 a.m. Today - BusinessWire - BZX
ALLERGAN, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 10:32 a.m. Today - PR Newswire - PRF
Valeant Comments On Allergan Announcement 9:29 a.m. Today - PR Newswire - PRF
Actavis to Acquire Allergan to Create Top 10 Global Growth Pharmaceutical Company with $23 Billion in Revenue 9:15 a.m. Today - PR Newswire - PRF
Physicians Continue to Voice Strong Support for Allergan via Open Letters to the Eye Care Community 9:00 a.m. Nov. 14, 2014 - BusinessWire - BZX
FDA Approves New Styles of Allergan’s NATRELLE® 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants 4:50 p.m. Nov. 12, 2014 - BusinessWire - BZX
Allergan Board of Directors Announces Approval of Amendments to Company’s Bylaws 7:02 a.m. Nov. 12, 2014 - BusinessWire - BZX
New Survey Reveals What Women in the U.S. Really Want to Know About BOTOX® Cosmetic (onabotulinumtoxinA) 8:47 a.m. Nov. 11, 2014 - PR Newswire - PRF
Ad hoc: Biofrontera to take over the sales and marketing of Ameluz(R) in Spain from Allergan 3:20 a.m. Nov. 7, 2014 - Thomson Reuters ONE
New Survey Shows Nearly 60% Of Women Say They Would Rather Have A More Youthful Looking Face Than A More Youthful Looking Body(1) 4:25 p.m. Nov. 5, 2014 - PR Newswire - PRF
Ipsen Biopharmaceuticals, Inc. Announces Hire of Donald Pearl as Vice President of Neurology 9:37 a.m. Nov. 5, 2014 - BusinessWire - BZX
Allergan Comments on California Federal Court Ruling in Insider Trading Lawsuit against Valeant & Pershing Square 1:56 p.m. Nov. 4, 2014 - BusinessWire - BZX
Valeant And Pershing Square May Vote At Special Meeting 1:27 p.m. Nov. 4, 2014 - PR Newswire - PRF
Quarterly Financial & Operational Results Release and Dividends - Research Reports on AFLAC, BlackRock, Allergan, Cabot and Cheniere Energy 8:40 a.m. Nov. 3, 2014 - PR Newswire - PRF
Allergan Canada Launches a 3D JUVEDERM(R) Visualization iPad App Powered by ModiFace 9:02 a.m. Oct. 29, 2014 - Marketwired
Allergan Comments on Valeant Letter 9:10 a.m. Oct. 27, 2014 - BusinessWire - BZX
Allergan Announces Quarterly Conference Call 1:00 p.m. Oct. 24, 2014 - BusinessWire - BZX
Global Pediatric Drugs and Vaccines Market 5:08 p.m. Oct. 23, 2014 - PR Newswire - PRF
Loading more headlines...
(0)
(0)Scroll down for more posts ▼